Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
2001 1
2008 1
2011 1
2012 3
2013 1
2014 2
2015 2
2016 2
2017 2
2018 2
2019 1
2021 1
2022 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Hemolytic uremic syndrome, atypical, childhood"
Page 1
Treatment and outcome of Shiga-toxin-associated hemolytic uremic syndrome (HUS).
Scheiring J, Andreoli SP, Zimmerhackl LB. Scheiring J, et al. Pediatr Nephrol. 2008 Oct;23(10):1749-60. doi: 10.1007/s00467-008-0935-6. Epub 2008 Aug 13. Pediatr Nephrol. 2008. PMID: 18704506 Free PMC article. Review.
Hemolytic uremic syndrome (HUS) is the most common cause of acute renal failure in childhood and the reason for chronic renal replacement therapy. ...D(+) HUS is an acute disease characterized by prodromal diarrhea followed by acute renal failure. The …
Hemolytic uremic syndrome (HUS) is the most common cause of acute renal failure in childhood and the reason for …
Extra-Renal manifestations of atypical hemolytic uremic syndrome in children.
Fidan K, Göknar N, Gülhan B, Melek E, Yıldırım ZY, Baskın E, Hayran M, Gülleroglu K, Özçakar ZB, Ozaltin F, Soylemezoglu O. Fidan K, et al. Pediatr Nephrol. 2018 Aug;33(8):1395-1403. doi: 10.1007/s00467-018-3933-3. Epub 2018 Apr 2. Pediatr Nephrol. 2018. PMID: 29610995
BACKGROUND: Atypical hemolytic uremic syndrome (aHUS) is a chronic disease characterized by thrombotic microangiopathy and a high risk of end-stage kidney disease. ...Interest in extrarenal manifestations of aHUS is increasing. This study aimed to dete …
BACKGROUND: Atypical hemolytic uremic syndrome (aHUS) is a chronic disease characterized by thrombotic microangi …
Novel aspects of atypical haemolytic uraemic syndrome and the role of eculizumab.
Verhave JC, Wetzels JF, van de Kar NC. Verhave JC, et al. Nephrol Dial Transplant. 2014 Sep;29 Suppl 4:iv131-41. doi: 10.1093/ndt/gfu235. Nephrol Dial Transplant. 2014. PMID: 25165180 Review.
The haemolytic uraemic syndrome (HUS) is part of a spectrum of thrombotic microangiopathies. ...With the introduction of eculizumab, a monoclonal anti-C5 inhibitor, in the clinical arena as effective treatment of most complement-mediated forms of HUS, a new era of t …
The haemolytic uraemic syndrome (HUS) is part of a spectrum of thrombotic microangiopathies. ...With the introduction of eculizumab, …
A Guide for Adult Nephrologists and Hematologists to Managing Atypical Hemolytic Uremic Syndrome and C3 Glomerulopathy in Teens Transitioning to Young Adults.
Riedl Khursigara M, Matsuda-Abedini M, Radhakrishnan S, Hladunewich MA, Lemaire M, Teoh CW, Noone D, Licht C. Riedl Khursigara M, et al. Adv Chronic Kidney Dis. 2022 May;29(3):231-242. doi: 10.1053/j.ackd.2022.04.003. Adv Chronic Kidney Dis. 2022. PMID: 36084970 Review.
Atypical hemolytic uremic syndrome and C3 glomerulopathy/immune complex membranoproliferative glomerulonephritis are ultra-rare chronic, complement-mediated diseases with childhood manifestation in a majority of cases. Transition of clinical …
Atypical hemolytic uremic syndrome and C3 glomerulopathy/immune complex membranoproliferative glomerulonephritis …
Efficacy and safety of eculizumab in childhood atypical hemolytic uremic syndrome in Japan.
Ito N, Hataya H, Saida K, Amano Y, Hidaka Y, Motoyoshi Y, Ohta T, Yoshida Y, Terano C, Iwasa T, Kubota W, Takada H, Hara T, Fujimura Y, Ito S. Ito N, et al. Clin Exp Nephrol. 2016 Apr;20(2):265-72. doi: 10.1007/s10157-015-1142-y. Epub 2015 Jul 9. Clin Exp Nephrol. 2016. PMID: 26156042
BACKGROUND: Atypical hemolytic uremic syndrome (aHUS) is a severe life-threatening disease with frequent progression to end-stage renal disease (ESRD). ...We, therefore, investigated the efficacy and safety of eculizumab in Japanese pediatric patients. …
BACKGROUND: Atypical hemolytic uremic syndrome (aHUS) is a severe life-threatening disease with frequent progres …
A new era in the diagnosis and treatment of atypical haemolytic uraemic syndrome.
Westra D, Wetzels JF, Volokhina EB, van den Heuvel LP, van de Kar NC. Westra D, et al. Neth J Med. 2012 Apr;70(3):121-9. Neth J Med. 2012. PMID: 22516576 Free article. Review.
The haemolytic uraemic syndrome (HUS) is characterised by haemolytic anaemia, thrombocytopenia and acute renal failure. ...Non-STEC or atypical HUS (aHUS) is seen in 5 to 10% of all cases and occurs at all ages. ...
The haemolytic uraemic syndrome (HUS) is characterised by haemolytic anaemia, thrombocytopenia and acute renal failure. ...Non-STEC o …
Atypical hemolytic uremic syndrome induced by CblC subtype of methylmalonic academia: A case report and literature review.
Chen M, Zhuang J, Yang J, Wang D, Yang Q. Chen M, et al. Medicine (Baltimore). 2017 Oct;96(43):e8284. doi: 10.1097/MD.0000000000008284. Medicine (Baltimore). 2017. PMID: 29068997 Free PMC article. Review.
Cobalamin C (CblC) type is the most frequent inborn error of cobalamin metabolism; it can develop symptoms in childhood and often combine multisystem damage, which leads to methylmalonic acid, propionic acid, methyl citrate, and other metabolites abnormal accumulation, cau …
Cobalamin C (CblC) type is the most frequent inborn error of cobalamin metabolism; it can develop symptoms in childhood and often com …
Factor H autoantibody is associated with atypical hemolytic uremic syndrome in children in the United Kingdom and Ireland.
Brocklebank V, Johnson S, Sheerin TP, Marks SD, Gilbert RD, Tyerman K, Kinoshita M, Awan A, Kaur A, Webb N, Hegde S, Finlay E, Fitzpatrick M, Walsh PR, Wong EKS, Booth C, Kerecuk L, Salama AD, Almond M, Inward C, Goodship TH, Sheerin NS, Marchbank KJ, Kavanagh D. Brocklebank V, et al. Kidney Int. 2017 Nov;92(5):1261-1271. doi: 10.1016/j.kint.2017.04.028. Epub 2017 Jul 24. Kidney Int. 2017. PMID: 28750931 Free PMC article.
Factor H autoantibodies can impair complement regulation, resulting in atypical hemolytic uremic syndrome, predominantly in childhood. There are no trials investigating treatment, and clinical practice is only informed by retrospective co …
Factor H autoantibodies can impair complement regulation, resulting in atypical hemolytic uremic syndrome, predo …
Eculizumab therapy in a child with hemolytic uremic syndrome and CFI mutation.
Cayci FS, Cakar N, Hancer VS, Uncu N, Acar B, Gur G. Cayci FS, et al. Pediatr Nephrol. 2012 Dec;27(12):2327-31. doi: 10.1007/s00467-012-2283-9. Epub 2012 Aug 19. Pediatr Nephrol. 2012. PMID: 22903728
BACKGROUND: Hemolytic uremic syndrome (HUS) is the most common cause of acute renal failure in childhood. ...Eculizumab (600 mg/week) was initiated on day 15 for atypical presentation and later a complement factor I (CFI) mutation was detected. …
BACKGROUND: Hemolytic uremic syndrome (HUS) is the most common cause of acute renal failure in childhood. ...Ecu …
Renal recovery with eculizumab in atypical hemolytic uremic syndrome following prolonged dialysis.
Povey H, Vundru R, Junglee N, Jibani M. Povey H, et al. Clin Nephrol. 2014 Nov;82(5):326-31. doi: 10.5414/CN107958. Clin Nephrol. 2014. PMID: 23557793
Hemolytic uremic syndrome (HUS) is a thrombotic microangiopathy (TMA) which encompasses hemolytic anemia, thrombocytopenia, and organ impairment. ...This case describes a young woman with clinical manifestations compatible with TMA during chi …
Hemolytic uremic syndrome (HUS) is a thrombotic microangiopathy (TMA) which encompasses hemolytic anemia, thromb …
20 results